Low Alanine Aminotransferase, as a Marker of Sarcopenia and Frailty, Is Associated with Shorter Survival Among Prostate Cancer Patients and Survivors. A Retrospective Cohort Analysis of 4064 Patients.

Laufer, Menachem; Perelman, Maxim; Sarfaty, Michal; Itelman, Edward; Segal, Gad

Laufer, Menachem; Perelman, Maxim; Sarfaty, Michal; Itelman, Edward; Segal, Gad.

Afiliação

Laufer M; Department of Urology, Chaim Sheba Medical Center, Ramat Gan, Israel.
Perelman M; Department of Internal Medicine T, Chaim Sheba Medical Center, Ramat Gan, Israel.
Sarfaty M; Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel.
Itelman E; Department of Internal Medicine E, Rabin Medical Center, Beilenson Campus, Peta-Tiqva, Israel.
Segal G; Cardiology Division, Rabin Medical Center, Beilenson Campus, Peta-Tiqva, Israel.

Eur Urol Open Sci ; 55: 38-44, 2023 Sep.

Article em En | MEDLINE | ID: mdl-37693730

Palavras-chave

Alanine aminotransferase; Frailty; Prostate cancer; Prostate-specific antigen; Sarcopenia; Survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Eur Urol Open Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google